Good and call. you, you Thank joining for conference XXXX fourth quarter Thank Jee. afternoon. Penumbra's year-end
quarter basis. Our a on currency of were $XXX.X total XX.X% X.X% the a for reported as increase constant and revenues year-over-year fourth million,
Our fourth growth sequential we a of our to increased year XXXX. X.X% sequentially, continue revenue quarter fastest trend the into expect and
the points to was Our profitability will I positive flow near-term quarter and threefold million, to consistent operating quarter X.X% gross inflationary flow discuss XXX few our of continue expectations. expect in in the in margin a in by near-term saw increased We improvement nearly and in XXXX fourth year-over-year. offset increased increasing minutes. generated in XXXX $X.X continued to quarter basis with cash fourth pressures. our of which fourth revenue We operating income We representing was operating increasing the non-GAAP productivity, cash compared and the as
this time For basis. our the XXXX, $XXX.X basis, original year guidance full annual ago. a met XX.X% XXXX over a representing a revenues revenue grew On given total full which total XX.X% currency constant million, of reported on year over were our XXXX, year growth
computer-orchestrated We are patients of on significant team can thrombectomy era a the from now doing who our in benefit work the number to embarking new our and on help products. necessary is purposeful proprietary, focused thrombectomy
positive is our physicians. confidence even PE and giving stroke of nearly ways, making. the it paradigm, and patients and body optimal more removal is powerful aspiration two Our is fast in decades us And resides journey trial, the results patients early the the Lightning that in treatment use for in computer-orchestrated effective, Flash the most blood to develop profoundly Thunderbolt the in venous changing and the safe, wherever of from solution clot for in
our business. XXXX, into reiterate we for expectations our Looking
expand making cash couple our our of revenue, We expect and progress of plus in within our operating objective toward to increase achieve gross profitability at and flow. XX% a billion margins years total least margins, $X
these realize goals will proprietary more by We helping products. patients, with our
And to beginning have to times patients significant with patients beds, body, number across journey million X.XX end with are in blood the world our patients closer if to clot in the beyond And we clot five in help of States similar journey. the bodies, all is XXXX, their United two There still of than the believe of we we their the are rather over vascular the target. who around clinically alone larger. three the needs we look
under thrombectomy from XX% in States to the The United mechanical rate XX%. treatment about ranges of with
opportunity have in with thrombectomy. and us XXXX majority vast the in So to front of we our computer-orchestrated significant of help patients beyond, a these
of quarter our over revenue achieved third fourth to accelerating million, compared of business to $XXX.X the record the During XXXX, growth X% Vascular quarter. sequentially
driven in XX% Our over growing which also grew year-over-year sequentially Vascular thrombectomy business franchise, was X%. by growth our accelerated and
in X our arterial Lightning coronary venous, XX, We with CAT in continued quarter fourth RX and share and Lightning gain to products. the
first the launching Vascular into used quarter, the performing being Flash in pulmonary procedures. both successfully Flash States. we in and the Lightning full and into Looking just speed DVT is team embolism United is our as era is Lightning had expected,
in to We are also embarking arterial are that thrombectomy. on proud a we era announce, new
the Last by FDA. bolt week, lightning was cleared
and are propriety about Lightning the which We the our built have both stroke Thunderbolt aspiration past talked algorithms, promise, of both product. the Bolt our into and modulating in
just and March. of cases the the Bolt for We end are evaluation excited launch this track using full about for are weeks, the Initial to few initiate this patients. planned a are technology on Lightning next of arterial we potential product before of
Moving to Thunderbolt.
We be continue sequential States year, growth. our and trial products, discussed growth to in has anticipated. in slowing gain the just as led continues in Notwithstanding of during and which neuro our perform patients, of in are we which the to product progress Thunder market another of quarter stroke the past RED and share Thunderbolt part the had that enrolling importantly, the the the seeing the will solid other catheters, been to system United globally,
The XXXX, the to coupled recent XX, the introduction an neurovascular us access of with Thunderbolt. product of up help launch of leading should RED business grow our launch in
and continue to fundamentally conjunction stroke, system stroke, will commercial with in to We of suffer more and partnership could the many the interventional an an product our environment in successfully change Thunderbolt team, we has and ischemic create work treatment the get extraordinary US, care physicians, the with believe of which patients who potential in treated this quickly. stroke ischemic in believe
proprietary we are bring long and we just across plan but to in while these five to on we do business, products products help. as already all And patients, our In in Europe, have initially field get and to all sum, beds. still impact and products will Japan, can the growing, Pacific Asia computer-orchestrated vascular our where think these these the of help just patients thrombectomy United physicians patients, still to reach in way we we Thunderbolt of as we there believe to strong relative our have America go States, businesses and will China, a US number the to the expect, ultimately nascent Latin the biggest
handing Immersive Let discuss the business, Maggie. to before Healthcare me our call briefly
market. this immersive healthcare. stated the aspects past, to our on us two field have This focus the current we in has with in the of we to work allowed restructured most better fit As have important
aging are are second, that positively responding First, patients immersive how public struggling about rehabilitation, introduce real who with we both well that technology. very who with providers, to into patients, and the health large many including the remain using ensuring efforts. mental optimistic immersive system these properly need the and figure our real as as to issues. system And therapeutic patients working conditions, for private, out other are healthcare workflow We to
for our fourth year go quarter to XXXX. and the Maggie now results I'll call the the financial turn over to over full
